OBJECTIVE: To determine whether pancreatic islet transplantation can control diabetes and prevent severe life-threatening hypoglycaemia. DESIGN, SETTING AND PARTICIPANTS: A single-arm observation study of six patients undergoing islet transplantation. All patients had had type 1 diabetes mellitus for over 5 years and documented episodes of repeated severe hypoglycaemia. Islets were isolated from donor pancreases digested by Liberase. Separated islets were infused into the recipient's liver via the portal vein. Patients were immunosuppressed with daclizumab, sirolimus and tacrolimus. The transplants were performed at Westmead Hospital, NSW, between October 2002 and February 2005. MAIN OUTCOME MEASURES: Normal blood glucose control without administration of exogenous insulin; demonstration of islet function and abolition of hypoglycaemia. RESULTS: Five of the patients received two islet infusions, and the sixth was withdrawn after one infusion following a portal vein thrombosis. Three patients became insulin-independent, with excellent glycaemic control. Two had islet function with circulating C-peptide, improved glycaemic control, reduced insulin requirement and abolition of severe hypoglycaemia. However, over a 2-year period, graft function deteriorated. Recipients who were initially insulin free remained C-peptide positive but required supplemental insulin. Complications included one postoperative bleed, two portal vein thromboses (which resolved completely), presumed recurrence of tuberculosis in one patient, and deterioration in renal function in one patient. CONCLUSIONS: Islet transplantation is effective at improving glycaemic control and hypoglycaemia unawareness in the short to medium term. However, problems with long-term safety of immunosuppression, islet-induced thrombosis and early detection of loss of islet function remain to be addressed.
OBJECTIVE: To determine whether pancreatic islet transplantation can control diabetes and prevent severe life-threatening hypoglycaemia. DESIGN, SETTING AND PARTICIPANTS: A single-arm observation study of six patients undergoing islet transplantation. All patients had had type 1 diabetes mellitus for over 5 years and documented episodes of repeated severe hypoglycaemia. Islets were isolated from donor pancreases digested by Liberase. Separated islets were infused into the recipient's liver via the portal vein. Patients were immunosuppressed with daclizumab, sirolimus and tacrolimus. The transplants were performed at Westmead Hospital, NSW, between October 2002 and February 2005. MAIN OUTCOME MEASURES: Normal blood glucose control without administration of exogenous insulin; demonstration of islet function and abolition of hypoglycaemia. RESULTS: Five of the patients received two islet infusions, and the sixth was withdrawn after one infusion following a portal vein thrombosis. Three patients became insulin-independent, with excellent glycaemic control. Two had islet function with circulating C-peptide, improved glycaemic control, reduced insulin requirement and abolition of severe hypoglycaemia. However, over a 2-year period, graft function deteriorated. Recipients who were initially insulin free remained C-peptide positive but required supplemental insulin. Complications included one postoperative bleed, two portal vein thromboses (which resolved completely), presumed recurrence of tuberculosis in one patient, and deterioration in renal function in one patient. CONCLUSIONS: Islet transplantation is effective at improving glycaemic control and hypoglycaemia unawareness in the short to medium term. However, problems with long-term safety of immunosuppression, islet-induced thrombosis and early detection of loss of islet function remain to be addressed.
Authors: Simon M Mwangi; Yousef Usta; Nikrad Shahnavaz; Irene Joseph; Jose Avila; Jose Cano; Veerappa K Chetty; Christian P Larsen; Shanthi V Sitaraman; Shanthi Srinivasan Journal: Transplantation Date: 2011-10-15 Impact factor: 4.939
Authors: W J Hawthorne; E J Salvaris; P Phillips; J Hawkes; D Liuwantara; H Burns; H Barlow; A B Stewart; S B Peirce; M Hu; A M Lew; S C Robson; M B Nottle; A J F D'Apice; P J O'Connell; P J Cowan Journal: Am J Transplant Date: 2014-05-19 Impact factor: 8.086
Authors: Rebecca A Stokes; Kim Cheng; Amit Lalwani; Michael M Swarbrick; Helen E Thomas; Thomas Loudovaris; Tom W Kay; Wayne J Hawthorne; Philip J O'Connell; Jenny E Gunton Journal: Diabetologia Date: 2017-07-22 Impact factor: 10.122
Authors: Wen Yuan Chung; Cristina A Pollard; Rohan Kumar; Christopher J Drogemuller; Bashoo Naziruddin; Cordula Stover; Eyad Issa; John Isherwood; Jill Cooke; Marlon F Levy; P Toby H Coates; Giuseppe Garcea; Ashley R Dennison Journal: Ann Transl Med Date: 2021-01